Bookmarks
NEURii
Description
{"type":"doc","content":[{"type":"paragraph","content":[{"type":"text","text":"Dementia is a significant public health issue affecting the lives of individuals, families, and wider communities. Diagnosis is often delayed, there are few treatments, and care pathways vary across the UK. The number of people living with dementia in the UK could reach 1.6 million by 2050 with an estimated cost to public healthcare of 47 billion pounds. Enabling better access to health data to improve our understanding of brain health has the potential to improve the lives of people living with dementia. Diagnosis is often delayed, there are few treatments, and care pathways vary across the UK."}]},{"type":"paragraph","content":[{"type":"text","text":"NEURii is an innovative and collaborative venture established by Eisai, Gates Ventures, HDR UK, LifeArc, and The University of Edinburgh. This groundbreaking partnership is dedicated to transforming the care and treatment of dementia by translating real-world data and digital science into actionable solutions and products. Through its pioneering work, NEURii seeks to enhance the lives of individuals living with dementia and their caregivers, helping people live longer and better lives worldwide."}]},{"type":"paragraph","content":[{"type":"text","text":"NEURii leverages cutting-edge technologies and methodologies to address the multifaceted challenges of dementia care. This includes:"}]},{"type":"bulletList","content":[{"type":"listItem","content":[{"type":"paragraph","content":[{"type":"text","text":"Integration of Real-World Data: By utilising high-quality, real-world data, NEURii can measure the real-world impact of its projects and explore opportunities to scale up digital health efforts across the UK and beyond."}]}]},{"type":"listItem","content":[{"type":"paragraph","content":[{"type":"text","text":"Digital Biomarkers: The initiative combines diverse digital biomarkers, such as speech patterns from conversations, which can be collected non-invasively in real-world clinical and non-clinical settings. These biomarkers are integrated with traditional health data to create comprehensive analytical models."}]}]},{"type":"listItem","content":[{"type":"paragraph","content":[{"type":"text","text":"Artificial Intelligence and Machine Learning: Tailored AI and ML algorithms are employed to analyse data and develop innovative digital solutions that predict, prevent, and manage dementia progression"}]}]}]},{"type":"paragraph","content":[{"type":"text","text":"NEURii operates within a robust governance framework designed to uphold public trust and ensure data security. The initiative adheres to FAIR data principles: Findability, Accessibility, Interoperability, and Reusability to maximise the utility of its datasets and tools. These principles are at the core of NEURii’s mission to provide transparent, ethical, and innovative solutions."}]}]}